Regulation of Glycogen Synthase Kinase-3 in Patients with Affective Disorders
- 15 January 2007
- journal article
- editorial
- Published by Elsevier in Biological Psychiatry
- Vol. 61 (2) , 139-141
- https://doi.org/10.1016/j.biopsych.2006.11.008
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell GrowthCell, 2006
- In Vivo Regulation of Glycogen Synthase Kinase-3β (GSK3β) by Serotonergic Activity in Mouse BrainNeuropsychopharmacology, 2004
- Attenuated 5‐HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3‐kinase, Akt and mitogen‐activated protein kinaseJournal of Neurochemistry, 2003
- Inhibitory Phosphorylation of Glycogen Synthase Kinase-3 (GSK-3) in Response to LithiumJournal of Biological Chemistry, 2003
- GSK-3: tricks of the trade for a multi-tasking kinaseJournal of Cell Science, 2003
- Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithiumNeuropharmacology, 2002
- An investigation of the Wnt-signalling pathway in the prefrontal cortex in schizophrenia, bipolar disorder and major depressive disorderSchizophrenia Research, 2002
- Lithium and valproic acid: parallels and contrasts in diverse signaling contextsPharmacology & Therapeutics, 2002
- Low GSK-3 activity in frontal cortex of schizophrenic patientsSchizophrenia Research, 2001
- Glycogen synthase kinase-3β, β-catenin, and tau in postmortem bipolar brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1999